Warfarin versus novel oral anticoagulants: how to choose?
RK Wadhera, CE Russell, G Piazza - Circulation, 2014 - Am Heart Assoc
… anticoagulant used. Recently, several other medications known as novel oral anticoagulants
(NOACs) have been studied and released on the market as alternatives to warfarin. Given …
(NOACs) have been studied and released on the market as alternatives to warfarin. Given …
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
CT Ruff, RP Giugliano, E Braunwald, EB Hoffman… - The Lancet, 2014 - thelancet.com
… new oral anticoagulant and 29 272 participants received warfarin. New oral anticoagulants
significantly reduced stroke or systemic embolic events by 19% compared with warfarin (RR 0…
significantly reduced stroke or systemic embolic events by 19% compared with warfarin (RR 0…
Guidelines on oral anticoagulation (warfarin): –2005 update.
TP Baglin, DM Keeling… - British journal of …, 2006 - search.ebscohost.com
… oral anticoagulant’ used in this update refers to oral vitamin K antagonists (VKA), such as
warfarin… of continued LMWH over oral anticoagulant therapy with warfarin in patients with …
warfarin… of continued LMWH over oral anticoagulant therapy with warfarin in patients with …
New oral anticoagulants: will they replace warfarin?
JW Little - Oral surgery, oral medicine, oral pathology and oral …, 2012 - Elsevier
… The present paper describes 2 new oral anticoagulant agents, dabigatran (a direct thrombin
inhibitor) and rivaroxaban (a factor Xa inhibitor). Dabigatran and rivaroxaban are licensed in …
inhibitor) and rivaroxaban (a factor Xa inhibitor). Dabigatran and rivaroxaban are licensed in …
Drug and dietary interactions of warfarin and novel oral anticoagulants: an update
E Nutescu, I Chuatrisorn, E Hellenbart - Journal of thrombosis and …, 2011 - Springer
… warfarin is continuously expanding, and the knowledge on drug interactions with the novel
oral anticoagulants is … interactions with warfarin and the novel oral anticoagulants, dabigatran, …
oral anticoagulants is … interactions with warfarin and the novel oral anticoagulants, dabigatran, …
Novel oral anticoagulants in atrial fibrillation: a meta‐analysis of large, randomized, controlled trials vs warfarin
A Dogliotti, E Paolasso, RP Giugliano - Clinical Cardiology, 2013 - Wiley Online Library
… large phase III trials of novel oral anticoagulants compared to warfarin in patients with atrial
… major benefits of the novel oral anticoagulants compared to warfarin are related to a lower …
… major benefits of the novel oral anticoagulants compared to warfarin are related to a lower …
Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart …
Medical Research Council's General Practice … - The Lancet, 1998 - Elsevier
… intensity of anticoagulation, … warfarin in our trial achieved a clear reduction in IHD, particularly
fatal events, providing further evidence that conventional intensities of oral anticoagulation …
fatal events, providing further evidence that conventional intensities of oral anticoagulation …
[HTML][HTML] Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation
… Currently, treatment with warfarin including regular international normalized ratio monitoring
costs less than $300 per annum. The new anticoagulants examined in this study cost more …
costs less than $300 per annum. The new anticoagulants examined in this study cost more …
Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control
A Janzic, M Kos - Pharmacoeconomics, 2015 - Springer
… Outcomes of warfarin treatment depend on the quality of anticoagulation control, which …
oral anticoagulants could be used as alternatives to warfarin treatment for stroke prevention …
oral anticoagulants could be used as alternatives to warfarin treatment for stroke prevention …
A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant
D Wadsworth, E Sullivan, T Jacky… - Journal of clinical …, 2021 - Wiley Online Library
… in 2010, direct oral anticoagulants (DOACs) have come to replace warfarin as the preferred
… for chronic anticoagulation, including venous thromboembolism (VTE) recurrence prevention …
… for chronic anticoagulation, including venous thromboembolism (VTE) recurrence prevention …
相关搜索
- direct oral anticoagulants
- cost effectiveness of new oral anticoagulants
- atrial fibrillation oral anticoagulants
- safety of new oral anticoagulants
- stroke prevention oral anticoagulants
- low intensity oral anticoagulation
- prevention of death oral anticoagulants
- nomenclature for oral anticoagulants
- use of novel oral anticoagulants
- dependent oral anticoagulants
- guidelines on oral anticoagulation
- old and new oral anticoagulants
- other new oral anticoagulants
- preferred oral anticoagulant
- oral anticoagulant dosing
- newer oral anticoagulants